Valeria Ossovskaya

The candidate tumour suppressor p33ING1cooperates with p53 in cell growth control

Igor Garkavtsev, Irina A. Grigorian, Valeria Ossovskaya et al. · Nature · 1998 · 294 citations

Medicine, Molecular Genetics, Oncology +14

Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types

Valeria Ossovskaya, Ingrid Chou Koo, Eric Kaldjian et al. · Genes & Cancer · 2010 · 281 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial

Joyce O’Shaughnessy, Cynthia R. Osborne, John Pippen et al. · Journal of Clinical Oncology · 2009 · 243 citations

Medicine, Oncology, Pharmacology +17

Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.

Valeria Ossovskaya, Ilya Mazo, Mikhail V. Chernov et al. · Proceedings of the National Academy of Sciences · 1996 · 173 citations

Life Sciences, Genetics, Molecular Biology +14

Agonists of proteinase‐activated receptor 1 induce plasma extravasation by a neurogenic mechanism

Lawrence de Garavilla, Nathalie Vergnolle, Steven H. Young et al. · British Journal of Pharmacology · 2001 · 140 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17